R
Roger Stupp
Researcher at Northwestern University
Publications - 463
Citations - 73077
Roger Stupp is an academic researcher from Northwestern University. The author has contributed to research in topics: Temozolomide & Glioma. The author has an hindex of 93, co-authored 430 publications receiving 63025 citations. Previous affiliations of Roger Stupp include Merck & Co. & University of St. Gallen.
Papers
More filters
Journal ArticleDOI
Book Review Lung Cancer: Principles and Practice Second edition. Edited by Harvey I. Pass, James B. Mitchell, David H. Johnson, Andrew T. Turrisi, and John D. Minna. 1177 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2000. $169. 0-7817-1791-4
Journal ArticleDOI
Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
Minesh P. Mehta,Michael Wang,Kenneth Aldape,Erik P. Sulman,Roger Stupp,K. Jaeckle,Deborah T. Blumenthal,Sara Erridge,W. Curran,Mark R. Gilbert +9 more
Book ChapterDOI
Malignant Glioma: Viewpoint—Chemotherapy
TL;DR: Randomized trials in anaplastic glioma have shown that the treatment sequence, radiotherapy first and chemotherapy at recurrence or the reverse, does not matter in terms of progression-free or overall survival.
Journal ArticleDOI
P01.042 Symptom clusters in newly diagnosed glioma patients: which clusters are associated with functioning and global health status?
Marijke B. Coomans,Linda Dirven,Neil K. Aaronson,Brigitta G. Baumert,Martin J. van den Bent,Andrew Bottomley,Alba A. Brandes,Olivier Chinot,Corneel Coens,Thierry Gorlia,Ulrich Herrlinger,Florence Keime-Guibert,Annika Malmström,Francesca Martinelli,Roger Stupp,Andrea Talacchi,Michael Weller,Wolfgang Wick,Jaap C. Reijneveld,Martin J B Taphoorn +19 more
Journal ArticleDOI
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Farshad Nassiri,Vikas Patil,Leeor S. Yefet,Olivia Singh,Jeff C. Liu,Takafumi N. Yamaguchi,Mariza Daras,Timothy F. Cloughesy,Howard Colman,Priya Kumthekar,Clark C. Chen,Robert Aiken,Morris D. Groves,Shirley Ong,Rohan Ramakrishna,Michael A. Vogelbaum,Simon Khagi,Thomas J. Lawley,Jason M. Melear,David M. Peereboom,Analiz Rodriguez,Maxim Yankelevich,Suresh G. Nair Md,Vinay K. Puduvalli,Kenneth Aldape,Andrew F. Gao,Alvaro López-Janeiro,Carlos E. de Andrea,Marta M. Alonso,P. Boutros,Joan M. Robbins,Warren P. Mason,Adam M. Sonabend,Roger Stupp,Juan Fueyo,Candelaria Gomez-Manzano,Frederick F. Lang,Gelareh Zadeh +37 more
TL;DR: In this article , the authors evaluated the combination of intratumoral delivery of oncolytic virus DNX-2401 followed by intravenous anti-PD-1 antibody pembrolizumab in recurrent glioblastoma.